Natural Killer Cells Therapeutics Market Size, Analysis, Growth, Future Demand and Leading Players Updates by Forecast To 2027

The IMARC Group provides extensive analysis of the natural killer cells therapeutics industry covering the market trends, investment opportunities, growth trends, statistics, and industry prospects. The report offers a comprehensive analysis of the industry, which comprises insights on market size, share, trends, analysis, growth, demand, statistics, and overview. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

Natural Killer Cells Therapeutics Market Overview:

The global natural killer cells therapeutics market reached a value of US$ 2.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a CAGR of 15.65% during 2022-2027. Natural killer (NK) cell therapeutics is a kind of cellular immunotherapy that uses lymphocytes as a medicinal agent for the treatment of various pathological challenges. They contain unique proteins, such as proteases and perforin or granzymes. NK cells approach and target foreign cells by releasing protein, which generates an immune system response in cases of viral infections and malignancies. They also help reduce the risk of cytokine storms and can be acquired from a variety of sources, thus eliminating the need for patient-specific immune cells.

Download a free sample report to get a detailed overview of the report: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market/requestsample

Natural Killer Cells Therapeutics Market Trends:

The increasing prevalence of various chronic disorders, such as cancer, infections, and liver diseases, and the growing demand for molecular and combinational therapies are some of the prime factors currently driving the global natural killer cell therapies market growth.  Additionally, the introduction of the ex vivo pre-conditioning approach and small molecular medications to enhance their therapeutic potential is propelling the market growth. Apart from this, significant improvements in the healthcare infrastructure and the ongoing research and development (R&D) activities to engineer bi-specific antibodies are contributing to the market growth. 

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Therapeutics, Application, End User, Region

Competitive Landscape with Key Players:

Affimed GmbH
Bristol-Myers Squibb Company
Fate Therapeutics
Fortress Biotech Inc.
Glycostem Therapeutics
Innate Pharma S.A.
Kuur Therapeutics Inc
Athenex Inc
Nkarta Inc.
Takeda Pharmaceutical Company Limited
Ziopharm Oncology Inc.

Breakup by Therapeutics:

NK Cell Therapies
NK Cell Directed Antibodies 

Breakup by Application:

Cancer 
Gastrointestinal Diseases
Immunoproliferative Disorders
Others

Breakup by End User:

Hospitals
Research Centers and Institutes 
Others

Breakup by Region:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for 10% free customized report: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                           

Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.